Last $44.06 USD
Change Today -0.50 / -1.12%
Volume 382.2K
MDSO On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

medidata solutions inc (MDSO) Snapshot

Open
$44.38
Previous Close
$44.56
Day High
$45.00
Day Low
$43.49
52 Week High
03/4/14 - $68.21
52 Week Low
05/7/14 - $32.10
Market Cap
2.4B
Average Volume 10 Days
390.3K
EPS TTM
$0.22
Shares Outstanding
54.0M
EX-Date
--
P/E TM
200.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIDATA SOLUTIONS INC (MDSO)

medidata solutions inc (MDSO) Related Bloomberg News

View More Bloomberg News

medidata solutions inc (MDSO) Related Businessweek News

No Related Businessweek News Found

medidata solutions inc (MDSO) Details

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences in the United States and internationally. The company’s software solutions allow customers to increase the value of their clinical development by designing, planning, and managing study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding, clinical business analytics, and data flow and interoperability. It offers Medidata Rave, a platform for capturing, managing, and reporting clinical data; Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, which enhances the efficiency of clinical trial start-up; Medidata Insights, a business analytics platform; and Medidata Balance, a randomization and trial supply management solution. The company also provides Medidata Patient Cloud that captures patient-reported outcomes; Medidata Grants Manager, which enables to develop and manage trial budgets; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and Medidata SQM, a set of cloud-based site quality management dashboards. In addition, it offers Medidata Coder that provides medical coding and synonym management solutions; Medidata Safety Gateway, which offers a solution for collecting and transmitting adverse events and related data from the EDC system; and Medidata Targeted SDV that provides auditable and scalable solutions, as well as offers hosting, support, and professional services. The company serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and academic institutions, medical centers, contract research organizations, and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.

medidata solutions inc (MDSO) Top Compensated Officers

Co-Founder, Chairman and Chief Executive Offi...
Total Annual Compensation: $475.0K
Co-Founder, President, Director and President...
Total Annual Compensation: $475.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $330.0K
Chief Value Officer and Executive Vice Presid...
Total Annual Compensation: $325.0K
Executive Vice President of Human Resources
Total Annual Compensation: $53.5K
Compensation as of Fiscal Year 2013.

medidata solutions inc (MDSO) Key Developments

Medidata Solutions, Inc. Presents at 2014 Needham Interconnect Conference, Aug-05-2014 02:00 PM

Medidata Solutions, Inc. Presents at 2014 Needham Interconnect Conference, Aug-05-2014 02:00 PM. Venue: The Westin Grand Central Hotel, New York, New York, United States. Speakers: Cory A. Douglas, Chief Financial Officer and Executive Vice President.

Medidata Solutions, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014; Reiterates Earnings Guidance for the Year 2014

Medidata Solutions, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company's total revenues were $83.2 million, an increase of $15.1 million, or 22%, compared with $68.1 million in 2013. GAAP operating income was $7.1 million, compared with $8.8 million in the second quarter of 2013. Non-GAAP operating income was $18.4 million, compared with $17.5 million a year ago. GAAP net income was $2.3 million, or $0.04 per diluted share, compared with $5.1 million, or $0.09 per diluted share, in the second quarter of 2013. Adjusted non-GAAP net income was $9.4 million, or $0.17 per diluted share, compared with $9.5 million, or $0.18 per diluted share, in the second quarter of 2013. Cash flow from operations was $24.1 million compared with $26.2 million a year ago. Income before income taxes was $3,705,000 against $8,858,000 a year ago. The company spent about $3 million in CapEx during the quarter. For the six months, the company reported total revenues of $159,863,000 against $131,328,000 a year ago. Operating income was $7,414,000 against $15,928,000 a year ago. Income before income taxes was $672,000 against $16,162,000 a year ago. Net income was $481,000 or $0.01 per diluted share against $10,806,000 or $0.20 per diluted share a year ago. Non-GAAP operating income was $30,887,000 against $31,701,000 a year ago. Adjusted non-GAAP net income was $15,343,000 or $0.28 per diluted share against $18,592,000 or $0.35 per diluted share a year ago. Net cash provided by operating activities was $17,814,000 against $29,068,000 a year ago. Purchase of furniture, fixtures and equipment was $11,602,000 against $6,761,000 a year ago. For the full year 2014, the company expects revenues between $340.0 and $345.0 million. Non-GAAP operating income between $80.0 and $83.0 million. Based on current estimates, this would equate to GAAP operating income between $28.5 and $31.5 million. Adjusted non-GAAP net income, which includes the tax affected adjustments primarily from stock-based compensation, non-cash interest expense associated with convertible senior notes and amortization at a 40% effective tax rate, between $41.0 and $44.0 million. Based on current estimates, this would equate to GAAP net income between $9.0 and $12.0 million. The company will spend about $15 million in CapEx for the full year.

Medidata Solutions, Inc. to Report Q2, 2014 Results on Jul 29, 2014

Medidata Solutions, Inc. announced that they will report Q2, 2014 results at 9:00 AM, Eastern Standard Time on Jul 29, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDSO:US $44.06 USD -0.50

MDSO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDSO.
View Industry Companies
 

Industry Analysis

MDSO

Industry Average

Valuation MDSO Industry Range
No financial data is available for MDSO.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIDATA SOLUTIONS INC, please visit www.mdsol.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.